Molecular Subtyping of Extensive Stage Small Cell Lung Cancer and Relevent Clinical Significance

Clinical trial NCT05933863 · COMPLETED

Trial details

NCT number: NCT05933863
Sponsor: Peking University Cancer Hospital & Institute
Status: COMPLETED
Study type: OBSERVATIONAL

SCLC,Extensive Stage

Start date: 2022-03-29
Primary completion: 2024-07-18
Enrollment: 168

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.